These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39080806)

  • 21. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
    Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
    Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-[
    Xu L; Huang G; Wang Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1729-1740. PubMed ID: 38150017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using
    Jiang X; Li T; Wang J; Zhang Z; Chen X; Zhang J; Zhao X
    Cancer Biother Radiopharm; 2024 Apr; 39(3):169-177. PubMed ID: 38193811
    [No Abstract]   [Full Text] [Related]  

  • 24. Prediction of HER2 Expression in Gastric Adenocarcinoma Based On Preoperative Noninvasive Multimodal
    Qin L; Chen W; Ye Y; Yi H; Pang W; Long B; Wang Y; Ye T; Li L
    Acad Radiol; 2024 Aug; 31(8):3200-3211. PubMed ID: 38302386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics in Gastric Cancer: First Clinical Investigation to Predict Lymph Vascular Invasion and Survival Outcome Using
    Yang L; Chu W; Li M; Xu P; Wang M; Peng M; Wang K; Zhang L
    Front Oncol; 2022; 12():836098. PubMed ID: 35433451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
    He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
    Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy.
    Li T; Xu M; Yang S; Wang G; Liu Y; Liu K; Zhao K; Su X
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2806-2818. PubMed ID: 38691111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine learning approach using
    Nakajo M; Hirahara D; Jinguji M; Ojima S; Hirahara M; Tani A; Takumi K; Kamimura K; Ohishi M; Yoshiura T
    Jpn J Radiol; 2024 Jul; 42(7):744-752. PubMed ID: 38491333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a Radiomics Model Based on
    Xue B; Jiang J; Chen L; Wu S; Zheng X; Zheng X; Tang K
    Front Oncol; 2021; 11():740111. PubMed ID: 34765549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-tumor metabolic heterogeneity of gastric cancer on
    Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H
    Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning analysis for the noninvasive prediction of lymphovascular invasion in gastric cancer using PET/CT and enhanced CT-based radiomics and clinical variables.
    Fan L; Li J; Zhang H; Yin H; Zhang R; Zhang J; Chen X
    Abdom Radiol (NY); 2022 Apr; 47(4):1209-1222. PubMed ID: 35089370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
    Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
    Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical application of
    Nakajo M; Jinguji M; Ito S; Tani A; Hirahara M; Yoshiura T
    Jpn J Radiol; 2024 Jan; 42(1):28-55. PubMed ID: 37526865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning based on clinico-biological features integrated
    Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on
    Zhang Y; Hu Y; Zhao S; Xu S
    Abdom Radiol (NY); 2024 Jun; 49(6):2027-2039. PubMed ID: 38526594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomics based on
    Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
    Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of a Computed Tomography-Based Model for Noninvasive Prediction of the T Stage in Gastric Cancer: Multicenter Retrospective Study.
    Tao J; Liu D; Hu FB; Zhang X; Yin H; Zhang H; Zhang K; Huang Z; Yang K
    J Med Internet Res; 2024 Oct; 26():e56851. PubMed ID: 39382960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.